Online investment platform eToro has won its bid to rely on late expert evidence in ASIC’s first-ever action alleging breach of obligations in designing and selling financial products over high-risk contracts for difference.
A landmark finding that Apple and Google misused their market power will boost competition claims — including class actions — against other dominant digital market players and could prompt the ACCC to consider action, experts told Lawyerly.
The Port Authority of NSW has won its claim for public interest immunity over six cabinet documents in a suit by a defunct sand importer over a lease agreement for a mulit-user facility at Glebe Island, with a judge finding they had little forensic value.
In a major win for two class actions and Fortnite maker Epic Games, a judge has found that Apple and Google misused their market power in running app stores and in-app purchase systems.
A rental company providing long-term leases for household items has been slugged with a $7.4 million penalty after a court found its loan agreements did not comply with credit laws.
Mayfield Development has been granted the High Court’s leave to make its argument that derivative Crown immunity does not apply to NSW Ports, in a seven-year-old competition case.
A judge that granted carriage of a Google ad tech class action to Maurice Blackburn and Phi Finney McDonald has reiterated concerns that such cooperative arrangements between firms could breach competition law.
A judge overseeing class actions against Coles and Woolworths over alleged illusory discounts has raised concerns about a bid to bind group members to findings in similar cases by the ACCC.
A judge has spiked Piper Alderman’s class action alleging Google abuses its dominance in digital advertising, favouring a competing case run jointly by two other firms, despite suggesting such arrangements hinted at lawyers “passing the prize around”.
Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.